| __timestamp | Taro Pharmaceutical Industries Ltd. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 759285000 | 4320000 |
| Thursday, January 1, 2015 | 862944000 | 2538000 |
| Friday, January 1, 2016 | 950751000 | 3337000 |
| Sunday, January 1, 2017 | 879387000 | 4003000 |
| Monday, January 1, 2018 | 661913000 | 8386000 |
| Tuesday, January 1, 2019 | 669893000 | 4461000 |
| Wednesday, January 1, 2020 | 644769000 | 1050000 |
| Friday, January 1, 2021 | 548970000 | 2963000 |
| Saturday, January 1, 2022 | 561347000 | 1772000 |
| Sunday, January 1, 2023 | 572952000 | 314000 |
| Monday, January 1, 2024 | 629182000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, Taro Pharmaceutical Industries Ltd. and Viridian Therapeutics, Inc. present a fascinating study in contrasts. Over the past decade, Taro has consistently outperformed Viridian, with revenues peaking in 2016 at approximately $950 million, before experiencing a gradual decline to around $573 million in 2023. This represents a 40% decrease from its peak, highlighting the challenges faced by established pharmaceutical companies in maintaining growth.
Conversely, Viridian Therapeutics, a smaller player, has seen its revenue fluctuate significantly, with a notable peak in 2018 at $8.4 million. However, by 2023, its revenue plummeted to just $314,000, indicating a staggering 96% drop. This stark contrast underscores the volatility and competitive pressures in the biotech sector. As we look to the future, the absence of 2024 data for Viridian suggests potential strategic shifts or market challenges that could redefine its trajectory.
Annual Revenue Comparison: Novo Nordisk A/S vs Viridian Therapeutics, Inc.
Revenue Insights: Pfizer Inc. and Taro Pharmaceutical Industries Ltd. Performance Compared
Revenue Insights: Gilead Sciences, Inc. and Viridian Therapeutics, Inc. Performance Compared
Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Who Generates More Revenue? Incyte Corporation or Taro Pharmaceutical Industries Ltd.
Breaking Down Revenue Trends: Dr. Reddy's Laboratories Limited vs Taro Pharmaceutical Industries Ltd.
Catalent, Inc. vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Exelixis, Inc. vs Taro Pharmaceutical Industries Ltd.
Revenue Showdown: Arrowhead Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. or Celldex Therapeutics, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Taro Pharmaceutical Industries Ltd. vs BioCryst Pharmaceuticals, Inc.
Taro Pharmaceutical Industries Ltd. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?